3-O-methyldopa uptake and inhibition of L-dopa at the blood-brain barrier.
D000818:Animals; D001682:Biological Availability; D001693:Biological Transport, Active; D001812:Blood-Brain Barrier; D001921:Brain / Q000378:metabolism; D002540:Cerebral Cortex / Q000378:metabolism; D003342:Corpus Striatum / Q000378:metabolism; D004058:Diffusion; D007031:Hypothalamus / Q000378:metabolism; D007700:Kinetics; D007980:Levodopa / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D008297:Male; D008636:Mesencephalon / Q000378:metabolism; D008750:Methyldopa / Q000097:blood / Q000378:metabolism*; D010300:Parkinson Disease / Q000188:drug therapy; D051381:Rats
D007980:Levodopa; D008750:Methyldopa